醋酸甲羟孕酮

  • 网络MPA;Medroxyprogesterone acetate;dmpa;Provera;medroxyprogesterone acetate, MPA
醋酸甲羟孕酮醋酸甲羟孕酮
  1. 建立了快速、灵敏的液相色谱-电喷雾串联质谱测定水产品中醋酸甲羟孕酮的残留量的方法。

    The method of determination of medroxyprogesterone acetate residue in aquatic product by liquid chromatography with electrospray ionisation tandem mass spectrometric detection is described .

  2. 方法:对30例EM患者采用保守性手术方法治疗,术后口服醋酸甲羟孕酮作巩固治疗。

    Methods : 30 cases of EM were administered medroxyprogesterone acetate after conservative surgery .

  3. NP方案联合醋酸甲羟孕酮治疗中晚期肺癌

    Combined NP Regimen with Medroxyprogesterone Acetate in Treatment for Advanced Lung Cancer

  4. RP-HPLC法测定人血浆中醋酸甲羟孕酮及片剂生物等效性研究

    Determination of medroxyprogesterone acetate in human plasma by RP-HPLC and study of bioequivalence

  5. 方法60例晚期肿瘤病人随机分为两组,A组30例为中药加醋酸甲羟孕酮,B组30例为单纯醋酸甲羟孕酮。

    Methods Sixty patients of advanced cancer were randomly divided into two groups , 30 patients in group A treated with TCM and MPA , 30 patients in group B treated with MPA .

  6. 醋酸甲羟孕酮(MPA)在激素依赖性肿瘤如肾癌、前列腺癌、乳腺癌等治疗上已取得显著疗效。

    Medroxyprogesterone acetate ( MPA ) in hormone-dependent tumors such as renal cancer , prostate cancer , breast cancer treatment has made a significant effect .

  7. 目的:探讨结合雌激素醋酸甲羟孕酮(Pre)替代防治绝经后妇女的血脂紊乱及心血管疾病。

    AIM : To investigate conjugated estrogens medroxyprogesterone acetate ( Pre ) in prevention and treatment of blood lipid disorder and cardiovascular disease for postmenopause women .

  8. 方法分别采用醋酸甲羟孕酮4~20mg/d口服和醋酸亮丙瑞林60~90μg/(kg·月),每4周1次,皮下注射治疗女童性早熟74例。

    Methods Seventy-four with CPP were treated with medroxyprogesterone acetate 4 ~ 20 mg / d orally and leuprorelin acetate 60 ~ 90 μ g / kg subcutaneously injection at monthly intervals .

  9. 目的观察醋酸甲羟孕酮(DMPA)对妇女骨质代谢的影响。

    Objective To observe the effect of depo-medroxyprogesterone acetate ( DMPA ) on bone metabolism in women .

  10. 方法:1)建立复方结合雌激素片剂中安宫黄体酮(又名:醋酸甲羟孕酮Medroxyprogesteroneacetate,MPA)和结合雌激素(ConjugatedEstrogens,CE)的含量测定方法一高效液相色谱法。

    Identification of medroxyprogesterone acetate tablets by infrared spectrophotometry Methods : 1 ) To develop a HPLC method for the determination of medroxyprogesterone acetate ( MPA ) and conjugated estrogens ( CE ) .

  11. 扫描方式为选择反应监测(SRM),用于定量分析的二级碎片离子m/z分别为327.4(醋酸甲羟孕酮)和325.4(醋酸甲地孕酮,内标)。

    The scanner mode was selection response monitor ( SRM ) . The second order fragment ion of monitor was at 327.4 ( medroxyprogesterone acetate ) and m / z 325.4 ( megestrol acetate , internal standard ) .

  12. 目的探讨不同剂量醋酸甲羟孕酮(DMPA)用于哺乳期妇女避孕对其避孕效果、副反应发生率及停用原因的影响。

    Objective To discuss the effects of contraception by different dosage of DMPA on the breast feeding women , as well as the side effects and the cause of having to stop the medicine .

  13. 方法将140例围绝经期和绝经后妇女随机分为4组,给药方案分别是:A组(35例):每日戊酸雌二醇(E2V)1mg+醋酸甲羟孕酮(MPA)2mg;

    Methods One hundred and forty peri - and post - menopausal women were randomly divided into 4 groups : group A ( 35 cases ) received estradiol valerate ( E_2V ) 1 mg + medroxyprogesterone acetate ( MPA ) 2 mg per day ;

  14. 术后巩固治疗推荐口服醋酸甲羟孕酮。

    Medroxyprogesterone acetate is recommended in the adjuvant treatment after surgery .

  15. 大气压化学电离质谱法测定饲料中的醋酸甲羟孕酮

    Determination of Medroxyprogesterone in Feed by LC - APCI - MS

  16. 醋酸甲羟孕酮长效避孕对骨代谢影响的临床研究

    Clinical research of long acting contraception of DMPA on bone metabolism

  17. 醋酸甲羟孕酮抑制血管生成的影响所致恶性肿瘤。

    Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by malignant neoplasm .

  18. 保守性手术联合长效醋酸甲羟孕酮治疗中重度子宫内膜异位症的临床观察

    Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis

  19. 首次使用长效醋酸甲羟孕酮患者2年中骨密度的改变

    Bone mineral density changes over two years in firsttime users of depot medroxyprogesterone acetate

  20. 不同剂量醋酸甲羟孕酮用于哺乳期妇女避孕的临床研究。

    A clinical study on contraception of breast-feeding women with different dosage of dmpa .

  21. 以AUC0-48计算的醋酸甲羟孕酮片剂的相对生物利用度为(100.3±6.9)%。

    The relative bioavailability of medroxyprogesterone acetate tablets was ( 100.3 ± 6.9 ) % .

  22. 目的建立醋酸甲羟孕酮片红外光谱鉴别方法。

    OBJECTIVE To establish a rapid and exclusive method for the identification of medroxyprogesterone acetate tablets .

  23. 口服马结合雌激素与醋酸甲羟孕酮对绝经妇女血清同型半胱氨酸水平的影响

    Effect of oral conjugated equine estrogen combined with medroxyprogesterone acetate on plasma homocysteine levels in postmenopausal women

  24. 醋酸甲羟孕酮对人结肠癌细胞体内外生长抑制作用的实验研究

    Experimental Study on Growth Inhibition of Medroxyprogesterone Acetate on Colonic Cancer Cells in Vitro and in Vivo

  25. 对接受长效醋酸甲羟孕酮避孕的青春期少女补充雌激素的双盲随机试验

    Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception

  26. 目的建立测定人血浆中醋酸甲羟孕酮的液相色谱-二级质谱联用法(LC-MS/MS)。

    OBJECTIVE To develop a sensitive and specific LCMS / MS method for the determination of medroxyprogesterone acetate in human plasma .

  27. 目的观察醋酸甲羟孕酮、醋酸亮丙瑞林治疗女童真性性早熟的疗效。

    Objective To evaluate the effect of medroxyprogesterone acetate and leuprorelin acetate in 74 female central precocious puberty ( CPP ) patients .

  28. 目的评价醋酸甲羟孕酮避孕针在中国妇女中常规使用时的避孕有效率、续用率、副反应和可接受程度。

    Objective To evaluate contraceptive efficacy , continuative rate of use , side effects and acceptability of depot medroxyprogesterone acetate ( DMPA ) injectable contraception preparation in Chinese women .

  29. 新西兰雌性未成年白兔40只随机分为空白对照组、阳性对照组及醋酸甲羟孕酮低、中、高剂量组,采用兔子宫内膜转化试验检测各组孕激素的活性。

    Young ( female ) rabbits of New Zealand were randomly divided into the different dosages groups , including control groups , detecting progestational activity by proliferation of rabbit endometrium .